21 CFR 201.6
§ 201.6 Drugs; misleading statements.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 201.6, § 201.6 Drugs; misleading statements, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/85753
- Permanent ID
ys:prov:85753@1- SHA-256
15e01f2d1314e8ab62103736926717495dabe53d4589f570184ccdef41b1cff6
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Among representations in the labeling of a drug which render such drug misbranded is a false or misleading representation with respect to another drug or a device or a food or cosmetic.
(b) The labeling of a drug which contains two or more ingredients may be misleading by reason, among other reasons, of the designation of such drug in such labeling by a name which includes or suggests the name of one or more but not all such ingredients, even though the names of all such ingredients are stated elsewhere in the labeling.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.